Prestige Consumer Healthcare, Inc. (PBH)
52.01
+0.70
(+1.36%)
USD |
NYSE |
Aug 24, 16:00
52.01
0.00 (0.00%)
After-Hours: 20:00
Prestige Consumer Healthcare Debt to Equity Ratio : 1.079 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.079 |
| March 31, 2026 | 0.5539 |
| December 31, 2025 | 0.59 |
| September 30, 2025 | 0.5704 |
| June 30, 2025 | 0.562 |
| March 31, 2025 | 0.5691 |
| December 31, 2024 | 0.5743 |
| September 30, 2024 | 0.6126 |
| June 30, 2024 | 0.6562 |
| March 31, 2024 | 0.6886 |
| December 31, 2023 | 0.7582 |
| September 30, 2023 | 0.833 |
| June 30, 2023 | 0.9021 |
| March 31, 2023 | 0.9447 |
| December 31, 2022 | 0.8582 |
| September 30, 2022 | 0.9036 |
| June 30, 2022 | 0.9465 |
| March 31, 2022 | 0.9548 |
| December 31, 2021 | 1.029 |
| September 30, 2021 | 1.116 |
| June 30, 2021 | 1.114 |
| March 31, 2021 | 1.115 |
| December 31, 2020 | 1.198 |
| September 30, 2020 | 1.242 |
| June 30, 2020 | 1.349 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.509 |
| December 31, 2019 | 1.504 |
| September 30, 2019 | 1.607 |
| June 30, 2019 | 1.631 |
| March 31, 2019 | 1.641 |
| December 31, 2018 | 1.494 |
| September 30, 2018 | 1.589 |
| June 30, 2018 | 1.716 |
| March 31, 2018 | 1.691 |
| December 31, 2017 | 1.687 |
| September 30, 2017 | 2.335 |
| June 30, 2017 | 2.499 |
| March 31, 2017 | 2.667 |
| December 31, 2016 | 1.770 |
| September 30, 2016 | 1.910 |
| June 30, 2016 | 2.139 |
| March 31, 2016 | 2.184 |
| December 31, 2015 | 2.007 |
| September 30, 2015 | 2.146 |
| June 30, 2015 | 2.286 |
| March 31, 2015 | 2.531 |
| December 31, 2014 | 2.690 |
| September 30, 2014 | 2.849 |
| June 30, 2014 | 1.655 |
| March 31, 2014 | 1.659 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Indivior Pharmaceuticals, Inc. | -2.447 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 4.569B |
| Total Liabilities (Quarterly) | 2.652B |
| Shareholders Equity (Quarterly) | 1.917B |
| Current Ratio | 3.230 |
| Net Debt Paydown Yield | -9.14% |